NASDAQ:ATOS

Atossa Genetics Stock Insider Trading

etoro logo Buy ATOS
*Your capital is at risk
$2.07
-0.120 (-5.48%)
At Close: Jul 31, 2026

Atossa Genetics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 27.46M and sold 100K ATOS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 27.46M shares
Sell 100K shares
98% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2023
Buy
Stock Option (right to buy)
A-Award
Weaver Gregory L
EVP & CFO
C-Suite Officer 2 600 000
Value: $2.39M
Jun 01, 2023
Buy
Stock Option (right to buy)
A-Award
Weaver Gregory L
EVP & CFO
C-Suite Officer 2 600 000
Value: $2.39M
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Weaver Gregory L
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Remmel H. Lawrence
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Steinhart Richard I
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Chen Shu-chih
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Galli Stephen J
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Galli Stephen J
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Chen Shu-chih
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Steinhart Richard I
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Remmel H. Lawrence
Director
Director 125 000
Value: $82.8K
May 04, 2023
Buy
Stock Option (right to buy)
A-Award
Weaver Gregory L
Director
Director 125 000
Value: $82.8K
Mar 02, 2023
Buy
Stock Option (right to buy)
A-Award
Quay Steven C
President & CEO
CEO / President 1 873 100
Value: $1.35M
Mar 02, 2023
Buy
Stock Option (right to buy)
A-Award
Guse Kyle
CFO, Gen Counsel And Secretary
C-Suite Officer 557 900
Value: $401.7K
Mar 02, 2023
Buy
Stock Option (right to buy)
A-Award
Guse Kyle
CFO, Gen Counsel And Secretary
C-Suite Officer 557 900
Value: $401.7K
Mar 02, 2023
Buy
Stock Option (right to buy)
A-Award
Quay Steven C
President & CEO
CEO / President 1 873 100
Value: $1.35M
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Chen Shu-chih
Director 50 000
Value: $0
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Chen Shu-chih
Director
Director 50 000
Value: $46.5K
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Weaver Gregory L
Director
Director 50 000
Value: $46.5K
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Weaver Gregory L
Director 50 000
Value: $0
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Steinhart Richard I
Director
Director 50 000
Value: $46.5K
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Steinhart Richard I
Director 50 000
Value: $0
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Remmel H. Lawrence
Director 50 000
Value: $0
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Galli Stephen J
Director 50 000
Value: $0
May 13, 2022
Buy
Stock Option (right to buy)
A-Award
Chen Shu-chih
Director
Director 50 000
Value: $46.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ATOSSA GENETICS INC.
Atossa Genetics
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE